However, knock-down of GSK-3α and 3β by small interfering RNA eliminated the enhancement of cell invasion and over-expressing WT- or S9A-GSK-3β also suppressed glioma cell invasion induced by EGF (Figure 4B). The gene discussed is GSK3A; the disease is central nervous system cancer.